Chase AIPricingFAQs
Display currency
Loading news…

Strominnate Therapeutics

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Lund, Skane Lan, Sweden Founded 2021 1-10 employees For Profit

Strominnate Therapeutics is the pioneer in the development of a new era for treating tumors and conditions of the nervous system.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
1
Patents
1

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
3
Patents granted
1
Trademarks
0
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$551.17K

Company Info

Founded
2021
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
HQ
Lund, Skane Lan, Sweden
Region
European Union (EU), Nordic Countries, Scandinavia

Signals & Scores

Heat score
High
Growth score
Low
Trend (7d)
5.5
Trend (30d)
2.6
Trend (90d)
7.6
1
professional contacts at Strominnate Therapeutics
Contact execs at Strominnate Therapeutics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Strominnate Therapeutics

Loading news…

FAQs about Strominnate Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
Strominnate Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments